rs35628234

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_199242.3(UNC13D):​c.2943G>A​(p.Glu981Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0494 in 1,577,316 control chromosomes in the GnomAD database, including 2,567 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.071 ( 558 hom., cov: 32)
Exomes 𝑓: 0.047 ( 2009 hom. )

Consequence

UNC13D
NM_199242.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.18

Publications

6 publications found
Variant links:
Genes affected
UNC13D (HGNC:23147): (unc-13 homolog D) This gene encodes a protein that is a member of the UNC13 family, containing similar domain structure as other family members but lacking an N-terminal phorbol ester-binding C1 domain present in other Munc13 proteins. The protein appears to play a role in vesicle maturation during exocytosis and is involved in regulation of cytolytic granules secretion. Mutations in this gene are associated with familial hemophagocytic lymphohistiocytosis type 3, a genetically heterogeneous, rare autosomal recessive disorder. [provided by RefSeq, Jul 2008]
UNC13D Gene-Disease associations (from GenCC):
  • familial hemophagocytic lymphohistiocytosis 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
  • hereditary hemophagocytic lymphohistiocytosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.4).
BP6
Variant 17-75830039-C-T is Benign according to our data. Variant chr17-75830039-C-T is described in ClinVar as Benign. ClinVar VariationId is 263238.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.18 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.138 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
UNC13DNM_199242.3 linkc.2943G>A p.Glu981Glu synonymous_variant Exon 30 of 32 ENST00000207549.9 NP_954712.1 Q70J99-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
UNC13DENST00000207549.9 linkc.2943G>A p.Glu981Glu synonymous_variant Exon 30 of 32 1 NM_199242.3 ENSP00000207549.3 Q70J99-1

Frequencies

GnomAD3 genomes
AF:
0.0713
AC:
10845
AN:
152156
Hom.:
553
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.141
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.0430
Gnomad ASJ
AF:
0.0634
Gnomad EAS
AF:
0.0260
Gnomad SAS
AF:
0.0835
Gnomad FIN
AF:
0.0342
Gnomad MID
AF:
0.0728
Gnomad NFE
AF:
0.0454
Gnomad OTH
AF:
0.0592
GnomAD2 exomes
AF:
0.0516
AC:
9828
AN:
190444
AF XY:
0.0536
show subpopulations
Gnomad AFR exome
AF:
0.145
Gnomad AMR exome
AF:
0.0232
Gnomad ASJ exome
AF:
0.0588
Gnomad EAS exome
AF:
0.0270
Gnomad FIN exome
AF:
0.0336
Gnomad NFE exome
AF:
0.0429
Gnomad OTH exome
AF:
0.0516
GnomAD4 exome
AF:
0.0471
AC:
67125
AN:
1425042
Hom.:
2009
Cov.:
31
AF XY:
0.0485
AC XY:
34184
AN XY:
705126
show subpopulations
African (AFR)
AF:
0.148
AC:
4902
AN:
33012
American (AMR)
AF:
0.0262
AC:
1005
AN:
38360
Ashkenazi Jewish (ASJ)
AF:
0.0575
AC:
1455
AN:
25326
East Asian (EAS)
AF:
0.0375
AC:
1441
AN:
38434
South Asian (SAS)
AF:
0.0903
AC:
7317
AN:
80986
European-Finnish (FIN)
AF:
0.0357
AC:
1814
AN:
50854
Middle Eastern (MID)
AF:
0.0717
AC:
410
AN:
5720
European-Non Finnish (NFE)
AF:
0.0417
AC:
45643
AN:
1093308
Other (OTH)
AF:
0.0531
AC:
3138
AN:
59042
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
4099
8199
12298
16398
20497
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1788
3576
5364
7152
8940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0713
AC:
10862
AN:
152274
Hom.:
558
Cov.:
32
AF XY:
0.0709
AC XY:
5275
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.141
AC:
5850
AN:
41540
American (AMR)
AF:
0.0430
AC:
657
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.0634
AC:
220
AN:
3470
East Asian (EAS)
AF:
0.0261
AC:
135
AN:
5176
South Asian (SAS)
AF:
0.0838
AC:
405
AN:
4832
European-Finnish (FIN)
AF:
0.0342
AC:
363
AN:
10622
Middle Eastern (MID)
AF:
0.0714
AC:
21
AN:
294
European-Non Finnish (NFE)
AF:
0.0454
AC:
3086
AN:
68024
Other (OTH)
AF:
0.0581
AC:
123
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
496
992
1489
1985
2481
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
114
228
342
456
570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0597
Hom.:
213
Bravo
AF:
0.0730
Asia WGS
AF:
0.0570
AC:
200
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Familial hemophagocytic lymphohistiocytosis 3 Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.40
CADD
Benign
9.0
DANN
Benign
0.85
PhyloP100
1.2
PromoterAI
-0.026
Neutral
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35628234; hg19: chr17-73826120; COSMIC: COSV52884810; COSMIC: COSV52884810; API